HFD-induced hepatic steatosis was less serious in the WT : HFD + OCN group than that in the WT : HFD + NS group, which suggested that uncarboxylated osteocalcin treatment remarkably attenuated HFD-induced hepatic steatosis (Figures 3(a), 3(b), 3(e), 3(f), and 3(i)). Here, BGLAP is linked to fatty liver disease.